id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
629699,ca51adf0-e4e1-4d94-8daf-84dee6969629,Q2,JAMES P. KEESE,74556,TEVA PHARMACEUTICALS USA,2008,second_quarter,PHA,"S. 623/Access to Life-Saving Medicine Act, S. 438/Fair Prescription Drug Competition Act, H.R. 806/Fair Prescription Drug Competition Act, H.R. 1956/Patient Protection and Innovative Biologic Medicines Act of 2007, H.R. 5629, H.R. 1038/Access to Life-Saving Medicine Act, S. 1505/Affordable Biologics for Consumers Act, S. 1695/Biologics Act of 2007, HR 3610","Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR)",40000,,0,0,2008-07-16T09:53:54-04:00